Viral recognition by the innate immune system: The role of pattern recognition receptors

Colombia Medica

Volumn 41, Issue 4, 2010, Pages 377-387

  Pedraza, Silvia Torres ^a   Betancur, Juan Guillermo ^a,b   Urcuqui Inchima, Silvio ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Innate immunity; Pro inflammatory cytokines; RIG I like receptors; Toll like receptors

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ADENOSINE DEAMINASE ACTING ON RNA; CHEMOKINE; CYTOKINE; IMIQUIMOD; INTERFERON; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE R; RESIQUIMOD; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOTHERAPY; INFECTION CONTROL; INNATE IMMUNITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRAL PHENOMENA AND FUNCTIONS; VIRAL RECOGNITION; VIRUS; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 78650727100     PISSN: 01208322     EISSN: 16579534     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
2. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009;227:221-33.
3. Janeway C, Jr., Medzhitov R. Viral interference with IL-1 and toll signaling. Proc Natl Acad Sci USA. 2000;97:10682-3.
4. Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leukoc Biol. 2004;75:749-55.
5. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, et al., Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity. 2009;31:873-84.
6. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001;107:13-9.
7. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol. 2004;4:499-511.
8. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett. 2003;85:85-95.
9. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, et al., Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol. 2003;77:4588-96.
10. Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A. 2006;103:17343-8.
11. Zhou S, Kurt-Jones EA, Mandell L, Cerny A, Chan M, Golenbock DT, et al., My D88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur J Immunol. 2005;35:822-30.
12. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, et al., Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol. 2002;76:8729-36.
13. Shehata MA, Abou El-Enein A, El-Sharnouby GA. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection. Egypt J Immun ol. 2006;13:141-52.
14. Gaudreault E, Fiola S, Olivier M, Gosselin J. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol. 2007;81:8016-24.
15. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al., Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004;101:5598-603.
16. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol. 2005;79:12658-66.
17. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol. 2001;75:10730-7.
18. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79:7269-72.
19. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al., Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1:398-401.
20. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, et al., IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta-and IL-18-associated myocarditis and coxsackievirus replication. J Immunol. 2003;170:4731-7.
21. Hahm B, Cho JH, Oldstone MB. Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology. 2007;358:251-7.
22. Tsai YT, Chang SY, Lee CN, Kao CL. Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol. 2008;11:604-615.
23. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, et al., Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A. 2004;101:3516-21.
24. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004;10:1366-73.
25. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196-200.
26. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RT, Libraty DH. Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition. J Immunol. 2006;177:7114-7121
27. Kumagai Y, Takeuchi, O., Akira, S. TLR9 as a key receptor for the recognition of DNA. Advanced drug delivery reviews. 2007;60:795-804.
28. Iacobelli-Martinez M, Nemerow GR. Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J Virol. 2007;81:1305-12.
29. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferonproducing cells through toll-like receptor 9. Blood. 2004;103:1433-7.
30. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198:513-20.
31. Ishii KJ, Akira S. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 2006;27:525-32. (Pubitemid 44515161)
32. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al., Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101-5.
33. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, et al., Cell type-specific involvement of RIG-I in antiviral response. Immunity. 2005;23:19-28.
34. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, et al., Essential role of mda-5 in type-I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA. 2006;103:8459-64.
35. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004;5:730-7.
36. Heim MH. RIG-I: an essential regulator of virus-induced interferon production. J Hepatol. 2005;42:431-3.
37. Hornung V, Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H. 5'-Triphosphate RNA is the ligand for RIG-I. Science. 2006;314:994-7.
38. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al., Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008;82:335-45.
39. Langland JO, Cameron, J. M., Heck, M. C., Jancovich, J. K., Jacobs, B. L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006;119:100-10.
40. Williams BR. Signal integration via PKR. Sci STKE. 2001;2001: RE2.
41. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14:778-809, table of contents.
42. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006;119:100-10.
43. Leroy MP, Baise EA, Pire GA, Desmecht DJ. Contribution of MX dynamin, oligoadenylate synthetase, and protein kinase R to anti-paramyxovirus activity of type 1 interferons in vitro. Am J Vet Res. 2007;68:988-94.
44. Umareddy I, Tang KF, Vasudevan SG, Devi S, Hibberd ML, Gu F. Dengue virus regulates type-I interferon signaling in a strain-dependent manner in human cell lines. J Gen Virol. 2008;89:3052-62.
45. Hartwig D, Schutte C, Warnecke J, Dorn I, Hennig H, Kirchner H, et al., The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferonalpha-stimulated host cells. J Viral Hepat. 2006;13:150-7.
46. Faller M, Guo F. MicroRNA biogenesis: there's more than one way to skin a cat. Biochim Biophys Acta. 2008;1779:663-7.
47. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, et al., The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity. 2008;29:538-50.
48. Nakhaei P, Hiscott J, Lin R. STINGing the antiviral pathway. J Mol Cell Biol. 2:110-2.
49. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signaling. Nature. 2008;455:674-8.
50. Yap MW, Nisole S, Lynch C, Stoye JP. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA. 2004;101:10786-91.
51. Funderburg N, Luciano AA, Jiang W, Rodriguez B, Sieg SF, Lederman MM. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One. 2008;3: e1915.
52. Asselin-Paturel C, Trinchieri G. Production of type-I interferons: plasmacytoid dendritic cells and beyond. J Exp Med. 2005;202:461-5.
53. Miller RL, Meng TC, Tomai MA. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect. 2008;21:69-87.
54. Brzozka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol. 2005;79:7673-81.
55. Conzelmann KK. Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negativestrand RNA viruses. J Virol. 2005;79:5241-8.
56. Feng Z, Cerveny M, Yan Z, He B. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol. 2007;81:182-92.
57. Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington WJ, Jr., et al., HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 2001;20:800-11.
58. Saira K, Zhou Y, Jones C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J Virol. 2007;81:3077-86.
59. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, et al., The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A. 2004;101:17264-9.
60. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O'Neill LA. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A. 2000;97:10162-7.
61. Tait SW, Reid EB, Greaves DR, Wileman TE, Powell PP. Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. J Biol Chem. 2000;275:34656-64.